Kingham J G, Parker D R
Department of Gastroenterology, Singleton Hospital, Swansea, UK.
Gut. 1998 Jan;42(1):120-2. doi: 10.1136/gut.42.1.120.
Coexistent primary biliary cirrhosis (PBC) and coeliac disease has been recorded but the association has not been systematically studied.
To determine relative prevalences of PBC and coeliac disease in a defined population over a 12 year period.
All patients with PBC or coeliac disease in a stable population of 250,000 in South Wales were identified from a clinical register and laboratory records.
Sixty seven patients with PBC and 143 patients with coeliac disease have been diagnosed and followed over a median of 86 (4-135) months; point prevalences in 1996 were 20 per 100,000 for PBC and 54 per 100,000 for coeliac disease. PBC in patients with coeliac disease was sought by investigating abnormal liver function tests. Ten (7%) had persistent abnormalities and three had PBC. Coeliac disease in patients with PBC was sought by investigating malabsorption, haematinic deficiency, positive antigliadin antibody, or coeliac disease family history. Eleven patients underwent duodenal biopsy revealing one further coeliac disease case. Four patients (three women have both conditions giving a point prevalence for patients with both conditions of 1.6 per 100,000 (95% confidence limits 0.44 to 4.1 per 100,000). Prevalence of PBC in patients with coeliac disease was 3% and of coeliac disease in patients with PBC was 6%.
A 12 year study of a stable 250,000 population revealed a relative prevalence of PBC in 3% of 143 patients with coeliac disease and of coeliac disease in 6% of 67 patients with PBC. PBC and coeliac disease are therefore associated. Screening for PBC in patients with coeliac disease using antimitochondrial antibody testing and screening for coeliac disease in patients with PBC with antigliadin antibody testing or duodenal biopsy are recommended.
原发性胆汁性肝硬化(PBC)与乳糜泻并存的情况已有记录,但尚未对二者的关联进行系统研究。
确定在一个特定人群中12年间PBC和乳糜泻的相对患病率。
从临床登记册和实验室记录中识别出南威尔士25万稳定人群中所有患有PBC或乳糜泻的患者。
已诊断出67例PBC患者和143例乳糜泻患者,并对其进行了中位时间为86(4 - 135)个月的随访;1996年PBC的点患病率为每10万人20例,乳糜泻为每10万人54例。通过调查肝功能异常来筛查乳糜泻患者中的PBC。10例(7%)患者存在持续异常,其中3例患有PBC。通过调查吸收不良、造血物质缺乏、抗麦胶蛋白抗体阳性或乳糜泻家族史来筛查PBC患者中的乳糜泻。11例患者接受了十二指肠活检,又发现1例乳糜泻病例。4例患者(3名女性)同时患有这两种疾病,两种疾病并存患者的点患病率为每10万人1.6例(95%可信区间为每10万人0.44至4.1例)。乳糜泻患者中PBC的患病率为3%,PBC患者中乳糜泻的患病率为6%。
一项对25万稳定人群进行的为期12年的研究显示,143例乳糜泻患者中有3%患有PBC,67例PBC患者中有6%患有乳糜泻。因此,PBC与乳糜泻有关联。建议对乳糜泻患者使用抗线粒体抗体检测筛查PBC,对PBC患者使用抗麦胶蛋白抗体检测或十二指肠活检筛查乳糜泻。